Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Journal of Gastroenterology
Published in: Clinical Journal of Gastroenterology 4/2016

01-08-2016 | Case Report

A case of simultaneous esophageal squamous cell carcinoma and Barrett’s adenocarcinoma

Authors: Tomoo Yamazaki, Yugo Iwaya, Mai Iwaya, Takayuki Watanabe, Ayako Seki, Yasuhide Ochi, Etsuo Hara, Tomohiro Sekiguchi, Noriko Hosaka, Norikazu Arakura, Eiji Tanaka, Osamu Hasebe

Published in: Clinical Journal of Gastroenterology | Issue 4/2016

Login to get access

Abstract

A 77-year-old male with a long history of alcohol consumption and smoking was admitted for hoarseness and dysphagia. Computed tomography revealed thickening of the middle intrathoracic esophageal wall and multiple mediastinal lymph node swellings. Esophagogastroduodenoscopic examination disclosed an advanced-stage squamous cell carcinoma lesion in the middle intrathoracic esophagus with synchronous early stage Barrett’s adenocarcinoma. The patient underwent endoscopic submucosal dissection for the adenocarcinoma followed by chemoradiation therapy for the squamous cell carcinoma. In spite of their common risk factors, the simultaneous manifestation of esophageal squamous cell carcinoma and Barrett’s adenocarcinoma is extremely rare and requires further study.
Literature
1.
Tachimori Y, Ozawa S, Fujishiro M, et al. Comprehensive registry of esophageal cancer in Japan 2006. Esophagus. 2014;11:21–47.CrossRef
2.
Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44:518–34.CrossRefPubMed
3.
Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á, et al. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21(26):7933–43.PubMedPubMedCentral
4.
de Jonge PJ, van Blankenstein M, Grady WM, et al. Barrett’s oesophagus: epidemiology, cancer risk and implications for management. Gut. 2014;63(1):191–202.CrossRefPubMed
5.
Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–9.CrossRefPubMed
6.
Yagi K, Nakamura A, Sekine A. Characteristic endoscopic and magnified endoscopic findings in the normal stomach without Helicobacter pylory infection. J Gastroenterol Hepatol. 2002;17:39–45.CrossRefPubMed
7.
The Japan Esophageal Society: Japanese Classification of Esophageal Cancer. 10th ed. Tokyo: Kanehara Shuppan; 2008
8.
9.
Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol. 2009;24:729–35.CrossRefPubMed
10.
Ariella M, Rosengard AM, Hamilton SR. Squamous carcinoma of the esophagus in patients with Barrett esophagus. Mod Pathol. 1989;2(1):2–7.
11.
Allan NK, Weitzner S, Scott L, et al. Adenocarcinoma arising in Barrett’s esophagus with synchronous squamous cell carcinoma of the esophagus. South Med J. 1986;79(8):1036–9.CrossRefPubMed
12.
Sheahan DG, Berman MA. Barrett’s mucosa with multiple carcinomas of the esophagus and oral cavity. J Clin Gastroenterol. 1986;8(1):103–7.CrossRefPubMed
13.
Geramizadeh B, Safari A, Javadi F, et al. Squamous cell carcinoma of the esophagus and adenocarcinoma of gastroesophageal junction, a rare coincidence. Iran Red Crescent Med J. 2011;13(7):507–9.PubMedPubMedCentral
14.
Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol. 2012;107(6):850–62.CrossRefPubMedPubMedCentral
15.
Yokoyama T, Yokoyama A, Kato H, et al. Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men. Cancer epidemiol Biomarker Prev. 2003;12:1227–33.
16.
Corley DA, Kubo A, Levin TR, et al. Helicobacter pylori infection and the risk of Barrett’s oesophagus: a community-based study. Gut. 2008;57(6):727–33.CrossRefPubMed
17.
Bollschweiler E, Schloesser T, Leers J, et al. High prevalence of colonic polyps in white males with esophageal adenocarcinoma. Dis Colon Rectum. 2009;52(2):299–304.CrossRefPubMed
18.
Balasubramanian G, Gupta N, Giacchino M, et al. Cigarette smoking is a modifiable risk factor for Barrett’s oesophagus. United Eur Gastroenterol J. 2013;1(6):430–7.CrossRef
19.
Toh Y, Oki E, Ohgaki K, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol. 2010;15(2):135–44.CrossRefPubMed
20.
Thrift AP, Cook MB, Vaughan TL, et al. Alcohol and the risk of Barrett’s esophagus:a pooled analysis from the International BEACON consortium. Am J Gastroenterol. 2014;109:1586–94.CrossRefPubMedPubMedCentral
21.
Iijima K, Koike T, Abe Y, et al. Extensive gastric atrophy:an increased risk factor of superficial esophageal squamous cell carcinoma in Japan. Am J Gastroenterol. 2007;102:1603–9.CrossRefPubMed
22.
Anderson LA, Murphy SJ, Johnson BT, et al. Relationship between Helicobacter pylory infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence:results from the FINBAR case–control study. Gut. 2008;57:734–9.CrossRefPubMed
Metadata
Title
A case of simultaneous esophageal squamous cell carcinoma and Barrett’s adenocarcinoma
Authors
Tomoo Yamazaki
Yugo Iwaya
Mai Iwaya
Takayuki Watanabe
Ayako Seki
Yasuhide Ochi
Etsuo Hara
Tomohiro Sekiguchi
Noriko Hosaka
Norikazu Arakura
Eiji Tanaka
Osamu Hasebe
Publication date
01-08-2016
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 4/2016
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-016-0653-8

Other articles of this Issue 4/2016

Clinical Journal of Gastroenterology 4/2016 Go to the issue

Case Report

Systemic immunoglobulin light-chain amyloidosis presenting hematochezia as the initial symptom

Case Report

Cholangiolocellular carcinoma with rapid progression initially showing abnormally elevated serum alfa-fetoprotein

Case Report

Acute appendicitis with a neuroendocrine tumor G1 (carcinoid): pitfalls of conservative treatment

Case Report

Neuroendocrine carcinoma of the pancreas with similar genetic alterations to invasive ductal adenocarcinoma

Case Report

Histological features of mixed neuroendocrine carcinoma and hepatocellular carcinoma in the liver: a case report and literature review

Clinical Review

Diagnosis and treatment of microscopic colitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits